IR-2024-001

IR-2024-001 is a developmental code used by Dong-A Pharmaceutical for two distinct healthcare programs. The primary program identified by this code is a **functional ingredient** for **respiratory health**, which is currently in the **preclinical** stage (in vitro and in vivo testing). This initiative aims to develop a health functional food ingredient to support respiratory function, potentially targeting inflammation or oxidative stress. Additionally, the code IR-2024-001 is associated with an **oral hygiene** project, also designated as **R-21-GA202**, which is in the **NDA/BLA** (Under Registration) phase. This oral hygiene program involves the development of **3D-printed oral solid dosage forms** and sustainable OTC packaging. Both programs are part of Dong-A Pharmaceutical's pipeline with expected milestones or launches targeted for 2025.